Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Phosphoglycerate mutase 1 pseudogene 10 (PGAM1P10) is a genomic DNA sequence classified as a pseudogene because it resembles the PGAM1 gene but contains sequence alterations that prevent it from producing a functional protein. Pseudogenes do not encode active proteins and typically lack biological function. Most available research and therapeutic attention is directed at functional PGAM1, an enzyme involved in glycolysis that is overexpressed in some cancers and is considered a potential anticancer target[1][2][3]. There is no evidence that PGAM1P10 has any role in disease, drug interaction, biomarker utility, or safety concerns, and it is not a molecular target for drugs or therapeutic interventions. If your query concerns the functional human enzyme "phosphoglycerate mutase 1" (PGAM1), please clarify, as this is a well-described glycolytic enzyme and bona fide oncology target, unrelated to the pseudogene PGAM1P10[1][2][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Phosphoglycerate mutase 1 pseudogene 10 (PGAM1P10).